logo-loader
CSE:HUGE NASDAQ:HUGE

FSD Pharma

Market:
CSE
Market Cap:
$53.74 m
Price
3.65 CAD
Change
-2.67%
52 weeks high
20.10
52 weeks low
3.35

In brief

FSD Pharma Inc. is a publicly-traded holding company, since May 2018.

FSD Pharma BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, ultramicronized-palmitoylethanolamide (“FSD201”), by down-regulating the cytokines to effectuate an anti-inflammatory response.